Bariatric Surgery Associated with a Lower Rate of Mortality Due to Infarction and Stroke

Prior bariatric surgery in a patient with morbid obesity is associated with a significant effect on survival after infarction or stroke.

TAVI: la estrategia minimalista es favorable en el EPOC severo

While these are observational data, the significant metabolic improvement experienced after the surgery can explain perfectly such findings.

This large nationwide registry of bariatric surgery found a 40% decrease in the risk of death, infarction, or stroke for these patients compared with patients who did not undergo such surgery. This benefit is still observed after individuals are matched by body mass index (BMI). There already are many small studies showing similar data for obese patients who undergo bariatric surgery. Bariatric surgery has also proven to be an effective and durable treatment for type 2 diabetes, although the mechanisms for such effect are not entirely understood.


Read also: Nonobstructive Coronary Lesions and Ventricular Dysfunction


The US bariatric surgery database sponsored by the Agency for Healthcare Research and Quality assessed 995,577 patients hospitalized for acute myocardial infarction and 917,610 for stroke over an 8-year period. Of these, 2218 patients with infarction and 2,168 with stroke had undergone prior bariatric surgery. Those patients were compared with a control group of morbidly obese patients with the same risk characteristics using propensity score matching.

Death due to infarction was 1.85% in patients with prior bariatric surgery compared with 3.03% in morbidly obese patients (p = 0.004). Similar results were observed with stroke: 1.43% vs. 2.74% (p = 0.001).

An analysis using BMI to match patients showed nearly identical results.


Read also: New Percutaneous Devices to Prevent Embolism in Atrial Fibrillation.


Bariatric surgery should have never been seen as a cosmetic procedure, but rather a tool to treat metabolic disease.

Original Title: Bariatric Surgery is Associated with a Lower Rate of Death after Myocardial Infarction and Stroke: a Nationwide Study.

Reference: Aminian A et al. Diabetes Obes Metab. 2019 May 3. [Epub ahead of print].

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

How real are the adverse effects of statins? Evidence from randomized clinical trials

The safety of statins continues to be a subject of debate, partly due to the extensive list of adverse effects included in prescribing information,...

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Dual Antiplatelet Therapy in Diabetic Patients with AMI: De-Escalation Strategy

Diabetes Mellitus (DM) is a common comorbidity in patients hospitalized for acute coronary syndrome (ACS) of increasing prevalence over the last decade, associated with...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

How real are the adverse effects of statins? Evidence from randomized clinical trials

The safety of statins continues to be a subject of debate, partly due to the extensive list of adverse effects included in prescribing information,...